Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Cordova Ventures" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Cordova Ventures for you to read. Along with our medical data and news we also list Cordova Ventures Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cordova Ventures Companies for you to search.
Aspect Ventures led the $10 million Series A round. BBG Ventures, LaunchCapital, iNovia, RiverPark Ventures, Ulu Ventures, Day One Ventures and Portfolia participated.
The Canadian startup secured C$62 million (or about $47.5 million) in a round led by TELUS Ventures. Wittington Ventures, OMERS, RBC Ventures, Real Ventures, Infinite Potential Group and BDC IT Venture Fund also participated in the round.
Oncology start-up VelosBio Inc. raised $58mm through its Series A round. Arix Bioscience and Sofinnova Ventures co-led and we...
System1 Biosciences Inc. (neurological and psychiatric disorder drug discovery using phenotypic screening) completed a $25mm ...
StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) rais...
Gauss Surgical Inc. (markets the Triton system for real-time blood loss monitoring during surgery and childbirth) raised $12....
Atomwise Inc. (AI using deep neural networks for drug discovery) closed a $45mm Series A round co-led by Monsanto Growth Vent...
Paradromics Inc. (implantable brain-machine interface (BMI) technology) brought in $7mm in a seed financing round co-led by A...
Diagnostics firm Glympse Bio Inc. raised $22mm through its Series A round that was co-led by LS Polaris Innovation Fund and A...
Kickstart Seed Fund led the round, and Purple Arch Ventures, SpringTime Ventures, Service Provider Capital and Lanoha Ventures also participated.
Ribometrix closed on a Series A financing worth $30 million. The round was led by M Ventures, with participation of new investors Amgen Ventures, Pappas Capital and Illumina Ventures.
Sutro Biopharma Inc. (oncology) raised $85.4mm through its Series E round. Samsara BioCapital and Surveyor Capital co-led and...
Evolve BioSystems Inc. (develops products to restore and maintain a healthy gut microbiome in infants) raised $40mm in its Se...
mPulse Mobile, a provider of mobile solutions to drive healthy behavior change has raised $11 million in Series B funding led by SJF Ventures including existing investors HLM Venture Partners, EchoHealth Ventures, OCA Ventures, and Bonfire Ventures. That latest round brings the company’s total funding to date to over $25 million. In addition to the ... Read More
Kymera Therapeutics Inc. (protein degradation-based drug discovery) raised $65mm through its Series B round. Bessemer Venture...
MS Ventures is the strategic, corporate venture arm of the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. They invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes. Along with the €100 million MS Ventures fund, their team also manages the €30 million Entrepreneur Partnershi...
Therapeutic antibody developer HiFiBio Therapeutics raised $37.5mm through an oversubscribed Series B round led by Sequoia Ch...
Eniac Ventures led the seed round. Nex Cubed, Oronoco Investments, Sway Ventures and Friedman BioVentures also participated.
The financing was led by Third Rock Ventures with participation from GV (formerly Google Ventures), Heritage Provider Network, Casdin Capital, Alexandria Venture Investments and others.
Gauss Surgical Inc. raised $12mm through its Series A round from Promus Ventures (led and takes a board seat), Summation Heal...
The startup, Deep Lens, is supported by seed financing from Sierra Ventures, Rev1 Ventures and Tamarind-Hill Fund.
Ribometrix Inc. (small-molecule therapies targeting RNA) raised $30mm in its Series A financing led by M Ventures, which adds...
In this interview, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Francesco de Rubertis of Index Ventures, Paul Stoffels, Worldwide Chairman of Johnson & Johnson Pharmaceuticals and Moncef Slaoui, Chairman of Research and Development at GSK about the launch of Index Ventures' new fund, IL
Life insurer funds Transamerica Ventures and SCOR Life & Health Ventures have made an investment "upward of seven figures" in -More-
Qiming Venture Partners led the Series B round, which also saw participation from Salesforce Ventures, Experian Ventures and The PNC Financial Services Group.